期刊文献+

螺内酯对PCI术中非干预侧心肌供血的影响

The influence of spironolactone on the coronary perfusion on the non-PCI side
原文传递
导出
摘要 目的探讨螺内酯干预对经皮冠状动脉介入治疗(PCI)围手术期心肌保护作用的可能机制。方法择期PCI患者121例随机分为治疗组(A组,63例)与对照组(B组,58例),A组在常规治疗基础上口服螺内酯20~40 mg/d,B组给予安慰剂。测定PCI非手术侧冠脉内术前与术后平均动脉压(MAP),同时测定并比较术后血醛固酮(Ald)、肌钙蛋白I(cTn-I)、C-反应蛋白(CRP)浓度变化。分析cTn-I变化值(ΔcTn-I)与其它变量间的相关性。结果二组术后Ald、cTn-I、CRP浓度均较术前有明显升高(P〈0.05),A组cTn-I明显低于B组(P〈0.05);A组术后的MAP均明显高于B组(P〈0.05);相关分析表明,ΔcTn-I与ΔCRP、ΔMAP间存在明显的相关性(r=0.61、r=0.38,P〈0.05)。结论螺内酯可增加PCI术后非手术侧冠脉的灌注;其机制可能与其能促进Ald的非基因组作用有关。 Objective To investigate the possible mechanism of spironolactone to protect myocardium during percataneous coronary intervention(PCI).Methods A total of 121 patients undergoing PCI were randomly divided into two groups of A(63 cases,conventional therapy plus spironolactone 20-40 mg/d) and B(58 cases,conventional therapy alone).Mean arterial pressure(MAP) of non-operated coronary artery was measured and blood aldosterone(Ald),troponin I(cTn-I) and C-reaction protein(CRP) were detected before and after PCI.The relationship between cTn-I and other datas was analysed.Results The blood levels of Ald,cTn-I and CRP were higher after PCI than those before in two groups(P0.05),which were higher in group A than those in group B(P0.05).The level of cTn-I in group A was lower than that in group B(P0.05).The MAP in group A was higher than that in group B(P0.05).The ΔcTn-I was positively correlated to ΔCRP and ΔMAP(r=0.61 and r=0.38,P0.05).Conclusion Spironolactonec could improve the perfusion of non-operated coronary artery in the patients uderwent PCI,which may be related with its non-genomic effects of Ald.
出处 《江苏医药》 CAS CSCD 北大核心 2011年第9期1031-1033,共3页 Jiangsu Medical Journal
基金 南通市科技局指导性课题(S9930)
关键词 螺内酯 冠心病 经皮冠状动脉介入 肌钙蛋白I Spironolactone Coronary heart disease Percataneous coronary intervention Troponin-I
  • 相关文献

参考文献7

二级参考文献12

  • 1王树岩,陈瑾,杨新春,池洪杰,刘秀兰.再灌注心律失常对急性心肌梗死患者心肌细胞凋亡和左室重构的影响[J].中华心血管病杂志,2007,35(1):59-62. 被引量:12
  • 2Losel R, Wehling M. Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol, 2003, 4 : 46 - 56.
  • 3Bohmer S, Carapito C, Wilzewski B, et al. Analysis of aldosterone-induced differential receptor-independent protein patterns using 2D-electrophoresis and mass spectrometry. Biol Chem, 2006, 387 : 917 -929.
  • 4Schmidt BM, Sammer U, Fleischmann I, et al. Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Hypertension, 2006, 47 : 650 - 655.
  • 5Gros R, Ding Q, Armstrong S, et al. Rapid effects of aldosterone on clonal human vascular smooth muscle cells. Am J Physiol Cell Physiol, 2007, 292 : 788 -794.
  • 6Michea L, Delpiano AM, Hitschfeld C, et al. Eplerenone blocks nongenomic effects of aldosterone on the Na ^+/H ^+ exchanger, intracellular Ca^2+ levels, and vasoconstriction in mesenteric resistance vessels. Endocrinology, 2005, 146 : 973 - 980.
  • 7Grossmann C, Benesic A, Krug AW, et al. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Mol Endocrinol, 2005, 19 . 1697 - 1710.
  • 8Bowley KA, Linley JE, Robins GG, et al. Role of protein kinase C in aldosterone-induced non-genomic inhibition of basolateral potassium channels in human colonic crypts. J Steroid Biochem Mol Biol, 2007, 104 : 45 - 52.
  • 9Watts BA 3rd, George T, Good DW. Aldosterone inhibits apical NHE3 and HCO3- absorption via a nongenomic ERK- dependent pathway in medullary thick ascending limb. Am J Physiol Renal Physiol, 2006, 291 : 1005 - 1013.
  • 10Le Moellic C, Ouvrard-Pascaud A, Capurro C, et al. Early nongenomic events in aldosterone action in renal collecting duct cells : PKCalpha activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response. J Am Soc Nephrol, 2004, 15 : 1145 - 1160.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部